A pilot study on the role of cytomegalovirus & human herpesvirus-6 infections in Indian bone marrow transplant recipients

Indian Journal of Medical Research

Volumn 114, Issue AUG., 2001, Pages 39-46

  Finny, G J ^a   Mathews, V ^a   Abraham, P ^a   Abraham, M ^a   Chandy, M ^a   Srivastava, A ^a   Nitsche, A ^b   Siegert, W ^b   Sridharan, G ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

^b HUMBOLDT UNIVERSITY   (Germany)

Author keywords

BMT; CMV; HHV 6; n PCR; Neutralizing antibodies

Indexed keywords

AD 1 ANTIBODY; GLYCOPROTEIN B AD-1 ANTIBODY; IMMUNOGLOBULIN M; LIVER ENZYME; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG; VIRUS DNA;

ACUTE DISEASE; ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ANTIBODY AFFINITY; ARTICLE; CHILD; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; CYTOPENIA; DISEASE ASSOCIATION; DISEASE MARKER; GRAFT VERSUS HOST REACTION; HERPES; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 6; IMMUNE DEFICIENCY; INCIDENCE; INDIA; INFANT; INFECTION; INFECTION CONTROL; INTERSTITIAL PNEUMONIA; NONHUMAN; PILOT STUDY; POLYMERASE CHAIN REACTION; RASH; REINFECTION; VIRUS REACTIVATION;

ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; CYTOMEGALOVIRUS INFECTIONS; HERPESVIRUS 6, HUMAN; HUMANS; INFANT; PILOT PROJECTS; ROSEOLOVIRUS INFECTIONS;

EID: 0035679519     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Cytomegalovirus infections after allogeneic bone marrow transplantation
2. Age-specific prevalence of complement-fixing antibodies to sixteen viral antigens: A computer analysis of 58,000 patients covering a period of eight years
3. Cytomegalovirus infection following liver transplantation: Review of literature
4. Control of cytomegalovirus-associated morbidity in renal transplant patients using intensive monitoring and either preemptive or deferred therapy
5. Infections due to the human herpes viruses in southern India: A seroepidemiological survey
6. Prevalence of cytomegalovirus antibody in young children in Vellore
7. Removal of cytomegalovirus DNA from donor blood by filtration
8. Immunologic evidence for frequent age-related cytomegalovirus reactivation in seropositive immunocompetent individuals
9. Reactivation and recombination of multiple cytomegalovirus strains from individual organ donors
10. Large-scale screening of human sera with cytomegalovirus recombinant antigens
11. Immunity induced by primary human cytomegalovirus infection protects against secondary infection among women of child bearing age
12. Neutralizing antibody responses to reinfecting strains of cytomegalovirus in transplant recipients
13. An ELISA using recombinant proteins for the detection of neutralizing antibodies against human cytomegalovirus
14. Antibodies to recombinant-derived glycoprotein B after natural human cytomegalovirus infection correlate with neutralizing activity
15. The humoral immune response against human cytomegalovirus is characterized by a delayed synthesis of glycoprotein-specific antibodies
16. Kinetics of the antibody response against human cytomegalovirus-specific proteins in allogenic bone marrow transplant recipients
17. Differentiation between acute primary and recurrent human cytomegalovirus infection in pregnancy, using a microneutralization assay
18. Evaluation of virological procedures to detect fetal human cytomegalovirus infection: Avidity of IgG antibodies, virus detection in amniotic fluid and material serum
19. Differentiation of primary cytomegalovirus infection from reactivation using the urea denaturation test for measuring antibody avidity
20. Human herpesvirus 6
21. Herpesvirus type 6 in patients undergoing bone marrow transplantation: Serologic features and detection by polymerase chain reaction
22. Seroconversion to human herpesvirus 6 following liver transplantation is a marker of cytomegalovirus disease
23. Cytomegalovirus
24. Enzyme-linked immunosorbent assay
25. Monitoring of leukocyte cytomegalovirus DNA in bone marrow transplant recipients by nested PCR
26. Avoiding false positives with PCR
27. Determination of cytomegalovirus DNA load for monitoring of cytomegalovirus disease and antiviral treatment in solid organ transplant patients, comparing limiting-dilution PCR and hybrid capture assay with cytomegalovirus isolation
28. Impact of oxidative stress on human cytomegalovirus replication and on cytokine-mediated stimulation of endothelial cells
29. Cytomegalovirus infection in a seroendemic renal transplantation - A longitudinal study of virological markers
30. Early occurrence of human cytomegalovirus infection after bone marrow transplantation as demonstrated by the polymerase chain reaction technique